Wells Fargo & Company Augmedix, Inc. Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
A detailed history of Wells Fargo & Company transactions in Augmedix, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 1,000 shares of AUGX stock, worth $2,350. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$2,350
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding AUGX
# of Institutions
48Shares Held
39.7MCall Options Held
0Put Options Held
0-
Redmile Group, LLC San Francisco, CA16.4MShares$38.5 Million2.52% of portfolio
-
Beryl Capital Management LLC Redondo Beach, CA4.49MShares$10.6 Million3.88% of portfolio
-
Dcm International Vi, Ltd.4.17MShares$9.8 Million5.31% of portfolio
-
Samjo Capital LLC2.91MShares$6.84 Million5.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.59MShares$3.73 Million0.0% of portfolio
About Augmedix, Inc.
- Ticker AUGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 37,421,200
- Market Cap $87.9M
- Description
- Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes...